Reducing Cardiovascular Side Effects of DMT Using Beta-Blockers.
ACS medicinal chemistry letters – May 08, 2025
Source: PubMed
Summary
Beta-blockers could be the key to making breakthrough psychedelic therapy safer and more accessible. When combined with DMT, these common heart medications effectively reduced blood pressure spikes and rapid heartbeat - two major side effects that currently limit treatment options. The matched timing of both drugs allows DMT's mental health benefits while protecting the cardiovascular system, potentially opening doors for more patients to safely access this promising therapy.
Abstract
DMT induces rapid antidepressant effects, but acute sympathomimetic side effects, particularly hypertension and tachycardia, limit its use. This study describes coformulations with short-acting beta-blockers or nitrates, matched to DMT's pharmacokinetics, to mitigate peripheral cardiovascular risks without compromising central therapeutic action, facilitating safer psychedelic therapy in vulnerable populations.